Wake Forest University Health Sciences
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Wake Forest University Health Sciences sits in the top decile of US sponsors by registered trial count (#27 of 15,742 sponsors by registered trial count).
Wake Forest University Health Sciences: 1,140 sponsored US clinical trials, 174 recruiting.
Wake Forest University Health Sciences sponsors 1,140 registered US clinical trials on ClinicalTrials.gov, 174 of them currently recruiting, and 724 completed. 111 of these trials are in Phase 3-4 (later-stage) and 239 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Breast Cancer, with 9 trials.
Top-decile sponsor footprint
Wake Forest University Health Sciences ranks in the top decile of sponsors by registered trial count (#27 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
724 of 885 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (81.8%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,140 total, page 6 of 23
Suzetrigine Frame Trial Comparing Suzetrigine and Acetaminophen
NCT07525219
Allograft vs. Autograft Nonunion
NCT07310082
Assessing Psoriasis Treatment Outcomes
NCT07391423
Patient Centered Simulation For Labor and Delivery
NCT03654079
Lumbar Drain With Intrathecal Nicardipine in Aneurysmal Subarachnoid Hemorrhage
NCT07246629
Assessing and Addressing Follow-up Care Needs That Will Facilitate Care Transitions for Cancer Survivors
NCT06654245
Comparing Technological and Relational Approaches to Support Families After a Missed Well Child Visit
NCT06686849
RCT-Consumer Perceptions of Cannabidiol (CBD) Health Claims
NCT06800066
A Randomized Controlled Trial to Test the Effects Oxytocin and Vibration Have on Heat Pain Threshold After UV-B Burn
NCT06651476
Using a Patient Navigator to Address the Social Drivers of Health in the Management of Pain
NCT06665906
Addressing Disparities in Diabetes Care
NCT06643611
Evaluation of Pharmacist Interventions in Lipid Management for Secondary Prevention
NCT06647238
Addressing Financial Hardship in Adolescent and Young Adult Cancer Survivors
NCT06881108
Evaluating Spinal Cord Stimulation for Stiff Person Syndrome
NCT06242678
GrowWell - Responsive Bottle Feeding
NCT06319807
Resident Posture Biofeedback Study
NCT06564519
Pedal Movement - Implementing Cycling as a Mobility Option
NCT06412991
A Portal-based Advance Care Planning Intervention Among Community-Dwelling Persons Living With Cognitive Impairment
NCT06509373
Investigating the Feasibility and Outcomes of Patient Self-Drain Removal After Ventral Hernia Repair
NCT06237855
Implementation of an Evidence-Based Intervention to Improve Head Impact Safety in Youth Football
NCT06368050
Text Intervention to Facilitate Secure Storage and Disposal of Prescription Opioids
NCT05503186
Education Session to Improve Program Adherence
NCT06428695
Va Meh Du Intervention
NCT06394193
Cannabis Edibles Packaging Imagery Experiment
NCT06358144
Relaxing Environment to Lower Anxiety During Onabotulinum Toxin Chemodenervation of the Bladder
NCT06319898
Sleep Well 24 (SWELL24) Healthy Sleep-Wake Behaviors in Older Adults
NCT05780983
Blood Flow Restriction Therapy Following Acute Shoulder Injury Patients
NCT06223373
Vivo Heart: Home-Based Virtual Exercise Program for Older Adults With Cardiovascular Disease
NCT05972850
Cannabis Edibles Packaging Descriptors Experiment
NCT06171399
Organization-level Youth Engagement Approach for Substance Misuse Prevention
NCT05736211
Anticipating Decline and Providing Therapy
NCT06182995
Storytelling To Prevent Obesity and Encourage Responsive Feeding Practices in Young Children
NCT05994924
Leveraging Social Innovation and Community-Engagement to Reduce Disparities in Outbreak Control Outcomes
NCT05123729
Pressure Relief Education and Training for Wheelchair Users
NCT06252597
Adapting a Sepsis Transition and Recovery Program for Optimal Scale Up
NCT05997420
ASPIRE: Adapting Self-Blood Pressure Monitoring to Reduce Health Disparities
NCT06175793
Temporary Peripheral Nerve Stimulation System for Osteoarthritis of the Knee
NCT06152029
Battlefield Auricular Acupressure (BAApress) Feasibility Study
NCT05939388
Cereset Research Long-Term Healthcare Worker Study
NCT05994261
Infracalcaneal Peppering Injection Technique for Chronic Plantar Fasciitis
NCT05868577
Consumer Perceptions of Cannabidiol (CBD) Health Claims
NCT06069713
A Comparison of the Outcomes in Fortiva and Strattice Mesh
NCT05572021
Tools for Anxiety and Depression Screening in Epilepsy
NCT05864612
Effect of Amifampridine on Neuromuscular Transmission in Patients Treated With OnabotulinumtoxinA
NCT05769478
Use of Dermabond in Mitigation of Spinal Cord Stimulation (SCS) Trial Lead Migration
NCT05914311
Feasibility of a Patient Directed Tool to Assess Heart Health Among Endometrial Cancer Survivors
NCT05796518
Implementation of a Mediterranean Diet Program for Overweight or Obese Pregnant Women in a Low-resource Clinical Setting
NCT05868954
Defining a PK and PD Model for Peripheral Analgesia After IV Oxytocin
NCT05929339
Perioperative Monitoring of Cardiac Surgery Patients With the Vitalstream Physiological Monitor
NCT05905536
Practice Patterns Among Gynecologic Oncologists on Tumor Genetic Testing in Endometrial Cancer
NCT05877404
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 96 |
| Phase 2 | 143 |
| Phase 3 | 31 |
| Phase 4 | 80 |
Therapeutic Areas
What is open in the Wake Forest University Health Sciences pipeline
174 recruiting of 1,140 indexed (15% open); 724 completed (64%).
Phase mix: 111 late (III/IV) vs 239 early (I/II) (early-phase heavy).
Top condition: Breast Cancer (9 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Wake Forest University Health Sciences: open-pipeline peers nationwide
Peers matched on 1,140 registered trials and 15% open enrollment, not the therapeutic-area sidebar.
Wake Forest University Health Sciences sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,140 trials (± recruiting share)
- University of Alabama at Birmingham · 1,160 trials · 19% recruiting
- NYU Langone Health · 1,164 trials · 17% recruiting
- University of North Carolina, Chapel Hill · 1,109 trials · 10% recruiting
- University of Florida · 1,106 trials · 15% recruiting
Sponsors near 15% open enrollment (± trial volume)
- Baylor University · 15% recruiting · 33 trials
- Cornell University · 15% recruiting · 66 trials
- Arrowhead Regional Medical Center · 15% recruiting · 13 trials
- Aurinia Pharmaceuticals · 15% recruiting · 13 trials
Related
What to do with this Wake Forest University Health Sciences page
1,140 registered trials is a research-attention snapshot, not an endorsement of Wake Forest University Health Sciences or any single study.
- 174 of Wake Forest University Health Sciences's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Breast Cancer is the condition Wake Forest University Health Sciences studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Breast Cancer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Wake Forest University Health Sciences pipeline card: 1,140 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.